Rachael N. Labitt
- Hepatology top 2%
- Hepatitis C virus research 4
- Virology top 10%
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 2
- Epidemiology top 10%
- Hepatitis B Virus Studies 3
-
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 2
-
- Cancer Immunotherapy and Biomarkers 2
-
- Animal Virus Infections Studies 2
-
- Systemic Lupus Erythematosus Research 2
- Co-authors
- Charles M. RiceAlexander PloßMarcus DornerBridget M. DonovanJoshua A. HorwitzMansun LawWilliam C. BudellJean K. Millet
- Partner nations
- United StatesCzechiaFrance
In The Last Decade
Rachael N. Labitt
14 papers receiving 686 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Hepatology 307
- Virology 63
- Infectious Diseases 158
- Epidemiology 276
- Immunology 133
Countries citing papers authored by Rachael N. Labitt
This map shows the geographic impact of Rachael N. Labitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachael N. Labitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachael N. Labitt more than expected).
Fields of papers citing papers by Rachael N. Labitt
This network shows the impact of papers produced by Rachael N. Labitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachael N. Labitt. The network helps show where Rachael N. Labitt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rachael N. Labitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2021 | 4 | |
| 4 | 2021 | 4 | |
| 5 | Comparing Phlebotomy by Tail Tip Amputation, Facial Vein Puncture, and Tail Vein Incision in C57BL/6 Mice by Using Physiologic and Behavioral Metrics of Pain and Distress. | 2017 | 15 |
| 6 | 2016 | 24 | |
| 7 | 2016 | 113 | |
| 8 | 2015 | 21 | |
| 9 | 2014 | 21 | |
| 10 | Broadly neutralizing antibodies abrogate established hepatitis C virus infectionbreakdown → | 2014 | 168 |
| 11 | 2013 | 41 | |
| 12 | Completion of the entire hepatitis C virus life cycle in genetically humanized micebreakdown → | 2013 | 171 |
| 13 | 2013 | 49 | |
| 14 | 2013 | 58 |
About Rachael N. Labitt
Rachael N. Labitt is a scholar working on Hepatology, Immunology and Virology, having authored 14 papers that have together received 692 indexed citations. Recurring topics across this work include Hepatitis C virus research (4 papers), Immunotherapy and Immune Responses (3 papers), Hepatitis B Virus Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Animal Virus Infections Studies (2 papers), Systemic Lupus Erythematosus Research (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Hepatology (307 citations), Virology (63 citations) and Infectious Diseases (158 citations). Rachael N. Labitt has collaborated with scholars based in United States, Czechia and France. Frequent co-authors include Charles M. Rice, Alexander Ploß, Marcus Dorner, Bridget M. Donovan, Joshua A. Horwitz, Mansun Law, William C. Budell, Jean K. Millet, Gary R. Whittaker and Kevin Vega.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.